Long-lasting antithrombotic effects of a single dose of human recombinant, active site-blocked factor VII: insights into possible mechanism(s) of action

J Thromb Haemost. 2003 May;1(5):992-8. doi: 10.1046/j.1538-7836.2003.00235.x.

Abstract

Tissue factor (TF) is important in initiating intravascular thrombosis. We demonstrated that active-site blocked factor VII (FVIIai) inhibits intravascular thrombosis for at least 6 h following a single injection, despite FVIIai plasma half-life was approximately 45 min. The aims of the present study were: (a) to determine the duration of the antithrombotic effects of a single injection of FVIIai; and (b) to assess whether FVIIai prolonged effects can be explained by a slow dissociation rate from TF in the arterial wall. Cyclic flow variations (CFVs), obtained in stenotic rabbit carotid arteries with endothelial injury, were abolished by either FVIIai (100 micro g kg-1 min-1 for 10 min) or hirudin (1 mg kg-1). After CFVs were abolished, carotid blood flow velocity was recorded continuously for 24 h. CFVs restored in all hirudin-treated animals after 2.1 +/- 0.3 h, while they restored in only four of nine FVIIai-treated rabbits in 10.1 +/- 2.2 h. Five animals in this group did not show restoration of CFVs up to 24 h. Immunohistochemistry revealed that FVIIai was still bound to the arterial wall 24 h following its administration, despite at this time FVIIai plasma levels were undetectable. Prothrombin time and partial thromboplastin time did not change significantly. FVIIai exerts potent, long-lasting antithrombotic effects without affecting systemic hemostatic parameters; a possible mechanism is a slow dissociation rate of FVIIai from TF. These proprieties make FVIIai particularly attractive as an antithrombotic intervention.

MeSH terms

  • Animals
  • Blood Coagulation / drug effects
  • Blood Coagulation Tests
  • Blood Flow Velocity / drug effects
  • Carotid Arteries / chemistry
  • Carotid Arteries / pathology
  • Carotid Arteries / physiopathology
  • Factor VII / analysis
  • Factor VII / pharmacokinetics*
  • Factor VII / pharmacology
  • Factor VIIa
  • Fibrinolytic Agents / analysis
  • Fibrinolytic Agents / pharmacokinetics*
  • Fibrinolytic Agents / pharmacology
  • Hirudins / pharmacokinetics
  • Hirudins / pharmacology
  • Immunohistochemistry
  • Rabbits
  • Recombinant Proteins / analysis
  • Recombinant Proteins / pharmacokinetics*
  • Recombinant Proteins / pharmacology
  • Thrombosis / drug therapy*
  • Thrombosis / prevention & control
  • Time Factors

Substances

  • Fibrinolytic Agents
  • Hirudins
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa